Character | Whole population (N = 204) | BMI < 30 kg m−2 (N = 94) | BMI ≥ 30 kg m−2 (N = 110) | p Value* | GDM−  (N = 62) | GDM+  (N = 142) | p Value* | BMI ≥ 30 kg m−2 AND GDM+  (N = 58) | p Value* |
---|---|---|---|---|---|---|---|---|---|
Age, years, Median, (IQR) | 39 (6.0) | 39 (6.0) | 38.5 (6.0) | 0.89 | 38 (6.0) | 39.0 (5.0) | 0.08 | 40 (5) | 0.086 |
BMI, kg m−2, median, (IQR) | 31.1 (10.9) | 25.0 (4.4) | 35.8 (6.0) |  | 35.0 (7.8) | 28.7 (9.3) |  < 0.001 | 34.5 (5.2) |  < 0.001 |
15D score, median (IQR) | 0.934 (0.092) | 0.947 (0.103) | 0.921 (0.083) |  < 0.001 | 0.930 (0.095) | 0.939 (0.090) | 0.72 | 0.927 (0.086) | 0.277 |
Intervention-group in the original study (%) | 96 (47.1%) | 49 (52.1%) | 47 (42.7%) | 0.16 | 27 (43.5%) | 69 (48.6%) | 0.61 | 22 (37.9%) | 0.100 |
Years of education number (%) | Â | Â | Â | 0.18 | Â | Â | 0.34 | Â | 0.553 |
Less than 9Â years | 3 (1.5%) | 2 (2.1%) | 1 (0.9%) | Â | 0 (0%) | 3 (2.1%) | Â | 1 (1.7%) | Â |
9–12 years | 19 (9.3%) | 7 (7.5%) | 12 (10.9%) |  | 5 (8.1%) | 14 (9.9%) |  | 8 (13.8%) |  |
13–16 years | 56 (27.5%) | 22 (23.4%) | 34 (30.9%) |  | 23 (37.1%) | 33 (23.2%) |  | 16 27.6%) |  |
More than 16Â years | 126 (61.8%) | 63 (67.0%) | 63 (57.3%) | Â | 34 (54.8%) | 92 (64.8%) | Â | 33 (56.9%) | Â |
Married/in a registered relationship/cohabiting (yes), number (%) | 186 (91.1%) | 89 (94.7%) | 97 (88.2%) | 0.10 | 57 (91.9%) | 129 (90.8%) | 0.06 | 49 (84.5%) | 0.068 |
Median number of children (< 18y) in the family, mean (min–max, IQR) | 2 (1–5, 1) | 2 (1–5, 1) | 2 (1–4, 0) | 0.032 | 2 (1–4, 1) | 2 (1–5, 1) |  < 0.001 | 2 (1–4, 1) | 0.539 |
Smoking regularly (yes), number (%) | 11 (5.4%) | 3 (3.2%) | 8 (7.3%) | 0.20 | 4 (6,5%) | 7 (4.9%) | 0.65 | 4 (6.9%) | 0.549 |
Prior GDM (yes), number (%) | 140 (68.6%) | 82 (87.2%) | 58 (52.7%) |  < 0.001 |  |  |  |  |  |
Reported one or more chronical disease (yes), number (%) | 62 (30.4%) | 20 (21.3%) | 42 (38.2%) | 0.018 | 23 (37.1%) | 39 (27.5%) | 0.17 | 27 (46.6%) | 0.372 |
Asthma or COPD (chronic obstructive pulmonary disease) | 15 (7.4%) | 6 (6.4%) | 9 (8.2%) | Â | 5 (8.1%) | 10 (7.0%) | Â | 5 (8.6%) | Â |
Migraine | 14 (6.9%) | 6 (6.4%) | 8 (7.3%) | Â | 2 (3.2%) | 12 (8.5%) | Â | 8 (13.8%) | Â |
Depression | 13 (6.3%) | 3 (3.2%) | 10 (9.1%) | Â | 5 (8.1%) | 8 (5.6%) | Â | 5 (8.6%) | Â |
Hypothyreoidism | 12 (5.9%) | 4 (4.3%) | 8 (7.3%) | Â | 6 (9.7%) | 6 (4.2%) | Â | 4 (6.9%) | Â |
Hypertension | 11 (5.4%) | 1 (1%) | 10 (9.1%) | Â | 4 (6.5%) | 7 (4.9%) | Â | 6 (10.3%) | Â |
Diabetes | 5 (2.5%) | 2 (2.1%) | 3 (2.7%) | Â | 1 (1.6%) | 4 (2.8%) | Â | 2 (3.4%) | Â |
Arrythmias | 3 (1.5%) | 2 (2.1%) | 1 (0.9%) | Â | 1 (1.6%) | 2 (1.4%) | Â | 0 (0%) | Â |
Rheumatoid arthritis | 2 (1%) | 1 (1%) | 1 (0.9%) | Â | 1 (1.6%) | 1 (0.7%) | Â | 0 (0%) | Â |
Cancer | 1 (0.5%) | 1 (1.1%) | 0 (0%) | Â | 0 (0%) | 1 (0.7%) | Â | 0 (0%) | Â |
Other | 18 (8.8%) | 9 (9.6%) | 9 (8.2%) | Â | 6 (9.7%) | 12 (8.5%) | Â | 7 (12.1%) | Â |